| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/28/2013 | US8450371 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 05/28/2013 | US8450370 Production of glycerol-related products from a high temperature reaction |
| 05/28/2013 | US8450369 Hypoglycemic oral drug for treating non-insulin dependent and insulin dependent diabetes |
| 05/28/2013 | US8450368 Heme oxygenase inhibitors, screening methods for heme oxygenase inhibitors and methods of use of heme oxygenase inhibitors for antimicrobial therapy |
| 05/28/2013 | US8450367 Sulfur derivatives as chemokine receptor modulators |
| 05/28/2013 | US8450366 Isobenzofuran analogs of sclerophytin A |
| 05/28/2013 | US8450365 Efficient synthesis of galanthamine |
| 05/28/2013 | US8450364 Use of equol for treating androgen mediated diseases |
| 05/28/2013 | US8450363 Inhibitors of Jun N-terminal kinase |
| 05/28/2013 | US8450362 Amidine-containing compounds useful as muscarinic receptor antagonists |
| 05/28/2013 | US8450361 Substituted indole and azaindole oxoacetyl piperazinamide derivatives |
| 05/28/2013 | US8450360 Process for preparing dithiine-tetracarboximides |
| 05/28/2013 | US8450359 Polymer-supported photosensitizers for the generation of singlet oxygen |
| 05/28/2013 | US8450358 Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents |
| 05/28/2013 | US8450357 Compositions comprising an aryl pyrazole and/or a formamidine, methods and uses thereof |
| 05/28/2013 | US8450356 Pharmaceutical composition |
| 05/28/2013 | US8450355 Compounds for the treatment of inflammatory diseases |
| 05/28/2013 | US8450354 Substituted imidazo[1,2-b]pyridazine derivatives, pharmaceutical compositions, and methods of use as β-secretase inhibitors |
| 05/28/2013 | US8450353 Topical compositions containing desthiobiotin and its derivatives and a method of treating skin |
| 05/28/2013 | US8450352 Thiazole compounds and their use for inhibiting phosphodiesterase 4, TNF-α, and IL-4 |
| 05/28/2013 | US8450351 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 05/28/2013 | US8450350 Triazoles as inhibitors of fatty acid synthase |
| 05/28/2013 | US8450349 Long acting dual release product containing carbinoxamine and pseudoephedrine |
| 05/28/2013 | US8450348 Such as 3-[6-(4-Chloro-phenoxy)-hexylamino]-4-(pyridin-4-ylamino)-cyclobut-3-ene-1,2-dione; cancer, tumors; reduced side effects |
| 05/28/2013 | US8450347 Administering a protein fraction, digestible carbohydrates, and a combination of folate, and one of vitamin B6 and vitamin B12. |
| 05/28/2013 | US8450346 Azetidine derivatives as FAAH inhibitors |
| 05/28/2013 | US8450345 Iminosugars and methods of treating viral diseases |
| 05/28/2013 | US8450344 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds |
| 05/28/2013 | US8450343 Gamma secretase modulators |
| 05/28/2013 | US8450342 Perharidines as CDK inhibitors |
| 05/28/2013 | US8450341 Substituted indolin-2-one derivatives and their use as P38 mitogen-activated kinase inhibitors |
| 05/28/2013 | US8450339 Compositions for treatment of common cold |
| 05/28/2013 | US8450338 Granular compositions of sodium picosulphate and potassium bicarbonate and uses thereof |
| 05/28/2013 | US8450337 Methods of treating skin disorders with caffeic acid analogs |
| 05/28/2013 | US8450336 Use of D-serine derivatives for the treatment of anxiety disorders |
| 05/28/2013 | US8450335 2,4-disubstituted pyrimidines useful as kinase inhibitors |
| 05/28/2013 | US8450334 Hepsin inhibitors |
| 05/28/2013 | US8450333 Molecules for regulating cell death |
| 05/28/2013 | US8450332 LIMK2 inhibitors, compositions comprising them, and methods of their use |
| 05/28/2013 | US8450331 Thiophenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as BACE-1 inhibitors, compositions, and their use |
| 05/28/2013 | US8450330 Pharmaceutical acceptable composition containing non-steroidal anti-inflammatory drug and local anesthetics |
| 05/28/2013 | US8450329 Benzoxazole kinase inhibitors and methods of use |
| 05/28/2013 | US8450328 Triazolo[4,5-D]pyramidine derivatives and their use as purine receptor antagonists |
| 05/28/2013 | US8450327 CGRP antagonists |
| 05/28/2013 | US8450326 Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases |
| 05/28/2013 | US8450325 Methods for reducing the recurrence of cardiac arrhythmia |
| 05/28/2013 | US8450324 Crystalline base of trans-1-((1R,3S)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine |
| 05/28/2013 | US8450323 Substituted derivatives of pyrido[3,2-e][1,4]thiazino[4,3-a]pyrazine and pyrido[3,2-e][1,4]oxazino[4,3-a]pyrazine |
| 05/28/2013 | US8450322 Substituted imidazo[1,2b]pyridazine compounds as Trk kinase inhibitors |
| 05/28/2013 | US8450321 6-(1H-indazol-6-yl)-N-[4-(morpholin-4-yl)phenyl]imidazo-[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor |
| 05/28/2013 | US8450320 Pyrrolopyrazinone inhibitors of kinases |
| 05/28/2013 | US8450319 Pyrrolopyridazinone compound |
| 05/28/2013 | US8450318 Method to treat infections using anti-infective agents |
| 05/28/2013 | US8450317 CXCR3 receptor antagonists |
| 05/28/2013 | US8450316 Niacin mimetics, and methods of use thereof |
| 05/28/2013 | US8450315 Phosphoinositide 3-kinase inhibitor compounds and methods of use |
| 05/28/2013 | US8450314 Pyrimidopyridazine derivatives useful as P38 MAPK inhibitors |
| 05/28/2013 | US8450313 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds |
| 05/28/2013 | US8450312 Micronized tanaproget, compositions, and methods of preparing the same |
| 05/28/2013 | US8450311 Pharmaceutical compositions containing a fluoroquinolone antibiotic drug |
| 05/28/2013 | US8450310 Isoxazole compounds as inhibitors of heat shock proteins |
| 05/28/2013 | US8450309 Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation |
| 05/28/2013 | US8450308 Inhibitors of beta-secretase |
| 05/28/2013 | US8450307 Therapeutic agents, and methods of making and using the same |
| 05/28/2013 | US8450306 Bradykinin B1-receptor antagonists |
| 05/28/2013 | US8450305 Macrocyclic compounds useful as inhibitors of kinases and HSP90 |
| 05/28/2013 | US8450304 4-azetidinyl-1-heteroaryl-cyclohexanol antagonists of CCR2 |
| 05/28/2013 | US8450303 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
| 05/28/2013 | US8450302 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors |
| 05/28/2013 | US8450301 Piperazine compounds with a herbicidal action |
| 05/28/2013 | US8450300 Fusidic acid dosing regimens for treatment of bacterial infections |
| 05/28/2013 | US8450299 Methods of hormonal treatment utilizing ascending-dose extended cycle regimens |
| 05/28/2013 | US8450297 Rapid two-step synthesis of anti-coagulants |
| 05/28/2013 | US8450296 Methods of use of biomaterial and injectable implant containing biomaterial |
| 05/28/2013 | US8450295 Ophthalmic composition containing xanthan gum and amino acid |
| 05/28/2013 | US8450294 Shampoo compositions |
| 05/28/2013 | US8450293 Synthesis and characterization of C8 analogs of c-di-GMP |
| 05/28/2013 | US8450292 Oligonucleotides or their functional homologues, a composition comprising the same and a method of treating B cell neoplasm |
| 05/28/2013 | US8450288 For introduction of a disc prosthesis or implant; involves providing substance(s) beneficial to the intervertebral disc through a cannulated element |
| 05/28/2013 | US8450287 Topical ophthalmic compositions containing tobramycin and dexamethasone |
| 05/28/2013 | US8450286 Method for treating cancers having high glucose requirements employing an SGLT2 inhibitor and compositions thereof |
| 05/28/2013 | US8450276 Non-toxic crosslinking reagents to resist curve progression in scoliosis and increase disc permeability |
| 05/28/2013 | US8450089 Compounds as L-cystine crystallization inhibitors and uses thereof |
| 05/28/2013 | US8449923 Methods for inhibiting sensory nerves by topically administering strontium-containing compositions to keratinized skin |
| 05/28/2013 | US8449918 Composition exhibiting enhanced formulation stability and delivery of topical active ingredients |
| 05/28/2013 | US8449914 releases carvedilol at least partly in R(+) or S(-) form after oral administration in such a manner that a prolonged residence of carvedilol is obtained In the circulatory system compared with the known carvedilol compositions |
| 05/28/2013 | US8449911 Drug composition having active ingredient adhered at high concentration to spherical core |
| 05/28/2013 | US8449910 Stable compositions of famotidine and ibuprofen |
| 05/28/2013 | US8449909 Abuse-deterrent drug formulations |
| 05/28/2013 | US8449908 Transdermal delivery of cannabidiol |
| 05/28/2013 | US8449907 Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl |
| 05/28/2013 | US8449906 Effervescent compositions comprising phosphonates and methods related thereto |
| 05/28/2013 | US8449900 Pesticide strips for control of mites in honeybees |
| 05/28/2013 | US8449899 Non-aqueous generation of chlorine dioxide |
| 05/28/2013 | US8449890 Neprilysin inhibitors |
| 05/28/2013 | US8449886 Combination of anti-CTLA4 antibody with tubulin modulating agents for the treatment of proliferative diseases |
| 05/28/2013 | US8449871 Composition comprising novel polyurethanes and cosmetic treatment process |
| 05/28/2013 | US8449867 Microemulsion and sub-micron emulsion process and compositions |
| 05/28/2013 | US8449863 Stabilized uncoated particles of reversed liquid crystalline phase materials |
| 05/28/2013 | CA2790294C .alpha.-crystalline form of carbabenzpyride |